FDA Panel Sees Risk in Long-Used Osteoporosis Drug

Bulletin Today | Personal HealthBy Matthew Perrone, Health Writer, The Associated Press WASHINGTON (AP) — A panel of federal health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer. The Food and Drug Administration panel voted 12-9 that the risks of the inhalable osteoporosis drug outweigh its benefits when used to treat brittle bones. The drug, known chemically as calcitonin salmon, has been …